NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Increase in Short Interest

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 112,100 shares, an increase of 26.0% from the February 28th total of 89,000 shares. Approximately 2.7% of the company’s stock are sold short. Based on an average trading volume of 226,500 shares, the short-interest ratio is currently 0.5 days.

NovaBay Pharmaceuticals Stock Performance

NovaBay Pharmaceuticals stock traded down $0.01 during midday trading on Wednesday, hitting $0.57. 26,897 shares of the stock were exchanged, compared to its average volume of 913,560. NovaBay Pharmaceuticals has a 52-week low of $0.36 and a 52-week high of $9.08. The stock has a market cap of $2.41 million, a PE ratio of -0.06 and a beta of 2.82.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.